News & Updates

Original New Drug Application Approvals by US FDA (16 - 30 April 2022)

05 May 2022

New drug applications approved by US FDA as of 16-30 April 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 30 April 2022)

05 May 2022

Adult-sized instruments feasible for use in paediatric percutaneous nephrolithotomy

04 May 2022

Performing percutaneous nephrolithotomy (PCNL) with adult-sized instruments in children yields comparable outcomes as when using paediatric-sized instruments, according to a study.

Adult-sized instruments feasible for use in paediatric percutaneous nephrolithotomy

04 May 2022

Dupilumab stops the itch, clears skin lesions in phase III trial

29 Apr 2022 by

The human monoclonal IgG4 antibody dupilumab effectively treats prurigo nodularis (PN), including itching and skin lesions, weeks after treatment in the phase III randomized, double-blind, LIBERTY-PN PRIME2 trial. Hopefully, this brings relief to patients suffering from uncontrolled PN.

Dupilumab stops the itch, clears skin lesions in phase III trial

29 Apr 2022

Lupus nephritis carries higher adverse outcomes in kids on dialysis

28 Apr 2022

Among children and adolescents undergoing maintenance dialysis, those with lupus nephritis are at higher risk of adverse outcomes, including hospitalization, and are less likely to receive kidney transplantation compared with those who have non-lupus glomerular disease, a study has found.

Lupus nephritis carries higher adverse outcomes in kids on dialysis

28 Apr 2022

Cutaneous reactions after 1st COVID-19 vaccine dose no reason to forgo 2nd dose

27 Apr 2022 by

Skin reactions to the first COVID-19 vaccine in some individuals shouldn’t be a reason to leave out the second dose, or a scheduled booster if tolerable, according to an analysis presented at AAD 2022.

Cutaneous reactions after 1st COVID-19 vaccine dose no reason to forgo 2nd dose

27 Apr 2022

Most children suffer from vitamin D deficiency

23 Apr 2022

Levels of 25-hydroxyvitamin D (25(OH)D) are deficient or insufficient in most children, reports a recent study. Aside from vitamin D intake, time spent outdoors and higher exposure to UV radiation seem to be effective methods of improving 25(OH)D status.

Most children suffer from vitamin D deficiency

23 Apr 2022

Nutrition-related claims mislead parents to choose less healthy drinks for kids

21 Apr 2022

A randomized trial in a virtual convenience store has shown the negative effect of nutrition-related claims that seem to encourage parents to select less healthy beverages for their children and mislead them on the healthfulness of fruit drinks.

Nutrition-related claims mislead parents to choose less healthy drinks for kids

21 Apr 2022

Treatment strategies, clinical variables predict relapse in paediatric CD

19 Apr 2022

The past decade has seen a decline in clinical relapses of paediatric luminal Crohn’s disease (CD), according to a study. Relapse risk is associated with clinical, endoscopic, histological, and laboratory variables and treatment strategies.

Treatment strategies, clinical variables predict relapse in paediatric CD

19 Apr 2022

Immersive virtual reality eases kids’ fear of needles

19 Apr 2022 by

The use of immersive virtual reality (VR) can help reduce fear and anxiety in children who are undergoing immunization in primary care, reports a recent Singapore study.

Immersive virtual reality eases kids’ fear of needles

19 Apr 2022

Original New Drug Application Approvals by US FDA (01 - 15 April 2022)

18 Apr 2022

New drug applications approved by US FDA as of 01-15 April 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01 - 15 April 2022)

18 Apr 2022

News & Updates

Filter by Specialty:

Specialty:

Original New Drug Application Approvals by US FDA (16 - 30 April 2022)

Original New Drug Application Approvals by US FDA (16 - 30 April 2022)

Adult-sized instruments feasible for use in paediatric percutaneous nephrolithotomy

Adult-sized instruments feasible for use in paediatric percutaneous nephrolithotomy

Dupilumab stops the itch, clears skin lesions in phase III trial

Dupilumab stops the itch, clears skin lesions in phase III trial

Lupus nephritis carries higher adverse outcomes in kids on dialysis

Lupus nephritis carries higher adverse outcomes in kids on dialysis

Cutaneous reactions after 1st COVID-19 vaccine dose no reason to forgo 2nd dose

Cutaneous reactions after 1st COVID-19 vaccine dose no reason to forgo 2nd dose

Most children suffer from vitamin D deficiency

Most children suffer from vitamin D deficiency

Nutrition-related claims mislead parents to choose less healthy drinks for kids

Nutrition-related claims mislead parents to choose less healthy drinks for kids

Treatment strategies, clinical variables predict relapse in paediatric CD

Treatment strategies, clinical variables predict relapse in paediatric CD

Immersive virtual reality eases kids’ fear of needles

Immersive virtual reality eases kids’ fear of needles

Original New Drug Application Approvals by US FDA (01 - 15 April 2022)

Original New Drug Application Approvals by US FDA (01 - 15 April 2022)